Gladius Capital Management LP Bioventus Inc. Transaction History

Gladius Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.33 - $5.75 $33,657 - $44,694	7,773 New	7,773 $40,000
Q2 2023 Dec 18, 2023	BUY	$0.93 - $3.64 $10,231 - $40,047	11,002 New	11,002 $31,000
Q2 2023 Aug 08, 2023	SELL	$0.93 - $3.64 $7,160 - $28,024	-7,699 Reduced 41.17%	11,002 $32,000
Q1 2023 Dec 18, 2023	BUY	$1.07 - $2.95 $20,010 - $55,167	18,701 New	18,701 $20,000
Q1 2023 May 09, 2023	BUY	$1.07 - $2.95 $280 - $772	262 Added 1.42%	18,701 $21,000
Q4 2022 Dec 18, 2023	BUY	$1.81 - $8.14 $33,374 - $150,093	18,439 New	18,439 $48,000
Q4 2022 Feb 02, 2023	BUY	$1.81 - $8.14 $33,374 - $150,093	18,439 New	18,439 $49,000

142

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $619M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Gladius Capital Management LP with notifications on news.